Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GLPG1690
GLPG1690
Galapagos Announces ISABELA Ph III Study in Idiopathic Pulmonary Fibrosis
CP Wire
Thu, 04/12/18 - 09:23 pm
Galapagos
GLPG1690
idiopathic pulmonary fibrosis
Galapagos Announces ISABELA Ph III Study in Idiopathic Pulmonary Fibrosis
Thu, 04/12/18 - 08:27 pm
Galapagos
GLPG1690
idiopathic pulmonary fibrosis
Good news from Galapagos’ pulmonary fibrosis product
GoInPharma
Wed, 08/16/17 - 09:42 pm
Galapagos
GLPG1690
idiopathic pulmonary fibrosis
Galapagos spotlights an ‘exciting’ round of PoC data for IPF drug, shares surge
Endpoints
Thu, 08/10/17 - 11:53 am
Galapagos
IPF
GLPG1690
FibroGen